PMID- 30240124 OWN - NLM STAT- MEDLINE DCOM- 20191104 LR - 20191104 IS - 1365-2982 (Electronic) IS - 1350-1925 (Linking) VI - 30 IP - 12 DP - 2018 Dec TI - Serum cholinesterase activity is elevated in female diarrhea-predominant irritable bowel syndrome patients compared to matched controls. PG - e13464 LID - 10.1111/nmo.13464 [doi] AB - BACKGROUND: Micro-inflammation is involved in the pathogenesis of irritable bowel syndrome (IBS). The parasympathetic nervous system, via acetylcholine (ACh), and its hydrolytic enzymes, plays a role in regulating inflammation. Increased serum cholinesterase activity, named cholinergic Status (CS), is associated with decreased inflammatory inhibition (ie, pro-inflammation). We assessed the association between IBS diarrhea-predominant (IBS-D) symptoms, CS, and inflammatory biomarkers. METHODS: Women with IBS-D were prospectively recruited. Serum acetylcholinesterase (AChE), CS, and high-sensitivity C-reactive protein (hs-CRP) levels were analyzed and fecal calprotectin (FC) in a subgroup of patients. The control group included women attending routine health checkups (matched by age and BMI). KEY RESULTS: Ninety-four women with IBS-D were compared to matched controls (1:1). Serum CS, AChE, and the AChE/butyrylcholinesterase (BChE) ratios were significantly increased in the IBS-D group compared to matched controls (P = 0.018, P = 0.001, and P = 0.004, respectively). Using a multiple logistic regression model, IBS-D was almost twice as likely in women with high CS compared to women with low CS (adjusted OR=1.84 (95% CI: 1.01-3.33), P = 0.045). Furthermore, IBS-D patients with higher hs-CRP levels demonstrated lower CS and BChE activity and elevated AChE and AChE/BChE ratios compared to patients with lower hs-CRP levels (P = 0.026, P = 0.036, P = 0.002; and P = 0.0007, respectively). CS was not correlated with the IBS symptoms score. CONCLUSIONS AND INFERENCES: This is the first study to explore the potential role of serum CS in IBS-D. The findings emphasize the possible role of the autonomic nervous system and its anti-inflammatory properties in IBS. CI - (c) 2018 John Wiley & Sons Ltd. FAU - Hod, Keren AU - Hod K AUID- ORCID: 0000-0002-8115-7274 AD - Department of Epidemiology and Preventive Medicine, School of Public Health, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. AD - Research Division, Epidemiology Service, Assuta Medical Centers, Tel Aviv, Israel. FAU - Sperber, Ami D AU - Sperber AD AD - Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel. FAU - Maharshak, Nitsan AU - Maharshak N AD - Department of Gastroenterology and Liver Diseases, Tel-Aviv Sourasky Medical Center, affiliated to the Sackler Faculty of Medicine, Tel Aviv, Israel. FAU - Ron, Yishay AU - Ron Y AD - Department of Gastroenterology and Liver Diseases, Tel-Aviv Sourasky Medical Center, affiliated to the Sackler Faculty of Medicine, Tel Aviv, Israel. FAU - Shapira, Izthak AU - Shapira I AD - Internal Medicine "C", "D" and "E", the Tel Aviv Sourasky Medical Center, affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel. FAU - David, Zeltser AU - David Z AD - Internal Medicine "C", "D" and "E", the Tel Aviv Sourasky Medical Center, affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel. FAU - Rogowski, Ori AU - Rogowski O AD - Internal Medicine "C", "D" and "E", the Tel Aviv Sourasky Medical Center, affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel. FAU - Berliner, Shlomo AU - Berliner S AD - Internal Medicine "C", "D" and "E", the Tel Aviv Sourasky Medical Center, affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel. FAU - Shenhar-Tsarfaty, Shani AU - Shenhar-Tsarfaty S AD - Internal Medicine "C", "D" and "E", the Tel Aviv Sourasky Medical Center, affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel-Aviv, Israel. FAU - Dekel, Roy AU - Dekel R AD - Department of Gastroenterology and Liver Diseases, Tel-Aviv Sourasky Medical Center, affiliated to the Sackler Faculty of Medicine, Tel Aviv, Israel. LA - eng PT - Journal Article DEP - 20180921 PL - England TA - Neurogastroenterol Motil JT - Neurogastroenterology and motility JID - 9432572 RN - 0 (Biomarkers) RN - EC 3.1.1.8 (Cholinesterases) SB - IM MH - Adolescent MH - Adult MH - Aged MH - Biomarkers/*blood MH - Case-Control Studies MH - Cholinesterases/*blood MH - Diarrhea/blood/enzymology/etiology MH - Female MH - Humans MH - Inflammation/blood/etiology MH - Irritable Bowel Syndrome/blood/complications/*enzymology MH - Middle Aged MH - Young Adult OTO - NOTNLM OT - acetylcholinesterase OT - cholinergic status OT - irritable bowel syndrome EDAT- 2018/09/22 06:00 MHDA- 2019/11/05 06:00 CRDT- 2018/09/22 06:00 PHST- 2018/05/23 00:00 [received] PHST- 2018/08/09 00:00 [revised] PHST- 2018/08/13 00:00 [accepted] PHST- 2018/09/22 06:00 [pubmed] PHST- 2019/11/05 06:00 [medline] PHST- 2018/09/22 06:00 [entrez] AID - 10.1111/nmo.13464 [doi] PST - ppublish SO - Neurogastroenterol Motil. 2018 Dec;30(12):e13464. doi: 10.1111/nmo.13464. Epub 2018 Sep 21.